Article révisé par les pairs
Titre:
  • Molecular targeted therapies in breast cancer: where are we now?
Auteur:Widakowich, Christian; Azambuja, Evandro; Gil, Thierry; Cardoso, Fatima; Dinh, Phuong; Awada, Ahmad; Piccart-Gebhart, Martine
Informations sur la publication:International journal of biochemistry & cell biology, 39, 7-8, page (1375-1387)
Statut de publication:Publié, 2007
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:Bevacizumab
Breast cancer
Lapatinib
Targeted therapy
Trastuzumab
MeSH keywords:Antibodies, Monoclonal -- adverse effects
Antibodies, Monoclonal -- therapeutic use
Antineoplastic Agents -- therapeutic use
Breast Neoplasms -- drug therapy
Chemotherapy, Adjuvant
Female
Genes, erbB-2 -- physiology
Humans
Quinazolines -- therapeutic use
Receptor, Epidermal Growth Factor -- metabolism
Receptors, Estrogen -- antagonists & inhibitors
Receptors, Estrogen -- metabolism
Tamoxifen -- therapeutic use
Note générale:Journal Article
Review
Langue:Anglais
Identificateurs:urn:issn:1357-2725
info:doi/10.1016/j.biocel.2007.04.015
info:pii/S1357-2725(07)00132-X
info:scp/34447092209
info:pmid/17543572